Ruili Zhu

机构：Zhengzhou University, Guangdong Provincial People's Hospital

发表论文 18 篇 · 总被引 422 次 · h-index 10

代表论文

• HBXIP drives metabolic reprogramming in hepatocellular carcinoma cells via METTL3‐mediated m6A modification of HIF‐1α (2020 · Journal of Cellular Physiology · 被引 117)
• Biology of the Tongue Coating and Its Value in Disease Diagnosis (2017 · Complementary Medicine Research · 被引 60)
• Sinomenine regulates CD14/TLR4, JAK2/STAT3 pathway and calcium signal via α7nAChR to inhibit inflammation in LPS-stimulated macrophages (2019 · Immunopharmacology and Immunotoxicology · 被引 51)
• Sinomenine inhibits fibroblast-like synoviocyte proliferation by regulating α7nAChR expression via ERK/Egr-1 pathway (2018 · International Immunopharmacology · 被引 47)
• Sinomenine inhibits macrophage M1 polarization by downregulating α7nAChR via a feedback pathway of α7nAChR/ERK/Egr-1 (2022 · Phytomedicine · 被引 36)
• Challenges Facing Percutaneous Ablation in the Treatment of Hepatocellular Carcinoma: Extension of Ablation Criteria (2021 · Journal of Hepatocellular Carcinoma · 被引 28)